Company Profiles

driven by the PitchBook Platform

Inflammatory Response Research

Inflammatory Response Research
2011 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$15k LATEST DEAL AMOUNT
$875k TOTAL AMOUNT RAISED
Description

Provider of drug development services for inflammatory disorders. The company focuses on pharmaceutical products for the treatment of inflammatory disorders and conditions. the company's products are oral combination of levocetirizine and montelukast for the treatment of influenza.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
515 East Micheltorena
Suite G
Santa Barbara, CA 93103
United States

+1 (805) 681-1522
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inflammatory Response Research’s full profile, request a free trial.

Inflammatory Response Research Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 04-Oct-2016 $15k $875k Completed Startup
1. Angel (individual) 02-Dec-2014 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Inflammatory Response Research Executive Team (2)

Name Title Board
Seat
Contact
Info
Chandler May MD Co-Founder, Board Member, President & Chief Executive Officer
Loriel May Co-Founder, Board Member & Chief Financial Officer